Examining Clinical Similarities Between Myalgic Encephalomyelitis/chronic Fatigue Syndrome and D-lactic Acidosis: a Systematic Review
Overview
General Medicine
Affiliations
Background: The pursuit for clarity in diagnostic and treatment pathways for the complex, chronic condition of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) continues. This systematic review raises a novel question to explore possible overlapping aetiology in two distinct conditions. Similar neurocognitive symptoms and evidence of D-lactate producing bacteria in ME/CFS raise questions about shared mechanisms with the acute condition of D-lactic acidosis (D-la).
Methods: D-la case reports published between 1965 and March 2016 were reviewed for episodes describing both neurological symptoms and high D-lactate levels. Fifty-nine D-la episodes were included in the qualitative synthesis comparing D-la symptoms with ME/CFS diagnostic criteria. A narrative review of D-la mechanisms and relevance for ME/CFS was provided.
Results: The majority of neurological disturbances reported in D-la episodes overlapped with ME/CFS symptoms. Of these, the most frequently reported D-la symptoms were motor disturbances that appear more prominent during severe presentations of ME/CFS. Both patient groups shared a history of gastrointestinal abnormalities and evidence of bacterial dysbiosis, although only preliminary evidence supported the role of lactate-producing bacteria in ME/CFS.
Limitations: Interpretation of results are constrained by both the breadth of symptoms included in ME/CFS diagnostic criteria and the conservative methodology used for D-la symptom classification. Several pathophysiological mechanisms in ME/CFS were not examined.
Conclusions: Shared symptomatology and underlying microbiota-gut-brain interactions raise the possibility of a continuum of acute (D-la) versus chronic (ME/CFS) presentations related to D-lactate absorption. Measurement of D-lactate in ME/CFS is needed to effectively evaluate whether subclinical D-lactate levels affect neurological symptoms in this clinical population.
Xie F, You Y, Gu Y, Xu J, Yao F JMIR Res Protoc. 2024; 13:e53347.
PMID: 38407950 PMC: 10928527. DOI: 10.2196/53347.
van Campen C, Rowe P, Visser F Medicina (Kaunas). 2023; 59(12).
PMID: 38138257 PMC: 10744908. DOI: 10.3390/medicina59122153.
Hypothesis: inflammatory acid-base disruption underpins Long Covid.
van der Togt V, Rossman J Front Immunol. 2023; 14:1150105.
PMID: 37122723 PMC: 10140510. DOI: 10.3389/fimmu.2023.1150105.
Rocha Martin V, DelHomme C, Chassard C, Schwab C, Braegger C, Bernalier-Donadille A Front Nutr. 2022; 9:902159.
PMID: 36071938 PMC: 9441890. DOI: 10.3389/fnut.2022.902159.
Kell D, Pretorius E Biochem J. 2022; 479(16):1653-1708.
PMID: 36043493 PMC: 9484810. DOI: 10.1042/BCJ20220154.